ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 83 filers reported holding ANTARES PHARMA INC in Q2 2013. The put-call ratio across all filers is 6.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $180,000 | +14.6% | 44,000 | 0.0% | 0.05% | +15.0% |
| Q4 2021 | $157,000 | -1.9% | 44,000 | 0.0% | 0.04% | -11.1% |
| Q3 2021 | $160,000 | -23.4% | 44,000 | -8.3% | 0.04% | -21.1% |
| Q2 2021 | $209,000 | -12.2% | 48,000 | -17.2% | 0.06% | -17.4% |
| Q1 2021 | $238,000 | -0.4% | 58,000 | -3.3% | 0.07% | -9.2% |
| Q4 2020 | $239,000 | +47.5% | 60,000 | 0.0% | 0.08% | +16.9% |
| Q3 2020 | $162,000 | -1.8% | 60,000 | 0.0% | 0.06% | -11.0% |
| Q2 2020 | $165,000 | +16.2% | 60,000 | 0.0% | 0.07% | -6.4% |
| Q1 2020 | $142,000 | -49.6% | 60,000 | 0.0% | 0.08% | -32.2% |
| Q4 2019 | $282,000 | +40.3% | 60,000 | 0.0% | 0.12% | +35.3% |
| Q3 2019 | $201,000 | +2.0% | 60,000 | 0.0% | 0.08% | +1.2% |
| Q2 2019 | $197,000 | +8.2% | 60,000 | 0.0% | 0.08% | +2.4% |
| Q1 2019 | $182,000 | +11.7% | 60,000 | 0.0% | 0.08% | -1.2% |
| Q4 2018 | $163,000 | -19.3% | 60,000 | 0.0% | 0.08% | +6.4% |
| Q3 2018 | $202,000 | +30.3% | 60,000 | 0.0% | 0.08% | +21.9% |
| Q2 2018 | $155,000 | +17.4% | 60,000 | 0.0% | 0.06% | -5.9% |
| Q1 2018 | $132,000 | +10.9% | 60,000 | 0.0% | 0.07% | +41.7% |
| Q4 2017 | $119,000 | -38.7% | 60,000 | 0.0% | 0.05% | -41.5% |
| Q3 2017 | $194,000 | +0.5% | 60,000 | 0.0% | 0.08% | +5.1% |
| Q2 2017 | $193,000 | +13.5% | 60,000 | 0.0% | 0.08% | +25.8% |
| Q1 2017 | $170,000 | +38.2% | 60,000 | 0.0% | 0.06% | +31.9% |
| Q4 2016 | $123,000 | +95.2% | 60,000 | 0.0% | 0.05% | +56.7% |
| Q3 2016 | $63,000 | 0.0% | 60,000 | 0.0% | 0.03% | +3.4% |
| Q2 2016 | $63,000 | +21.2% | 60,000 | 0.0% | 0.03% | +20.8% |
| Q1 2016 | $52,000 | -28.8% | 60,000 | 0.0% | 0.02% | -31.4% |
| Q4 2015 | $73,000 | -28.4% | 60,000 | 0.0% | 0.04% | -28.6% |
| Q3 2015 | $102,000 | -18.4% | 60,000 | 0.0% | 0.05% | -3.9% |
| Q2 2015 | $125,000 | +83.8% | 60,000 | +140.0% | 0.05% | +82.1% |
| Q1 2015 | $68,000 | +6.2% | 25,000 | 0.0% | 0.03% | +7.7% |
| Q4 2014 | $64,000 | +39.1% | 25,000 | 0.0% | 0.03% | +30.0% |
| Q3 2014 | $46,000 | -31.3% | 25,000 | 0.0% | 0.02% | -25.9% |
| Q2 2014 | $67,000 | -23.0% | 25,000 | 0.0% | 0.03% | -28.9% |
| Q1 2014 | $87,000 | -22.3% | 25,000 | 0.0% | 0.04% | -22.4% |
| Q4 2013 | $112,000 | +10.9% | 25,000 | 0.0% | 0.05% | 0.0% |
| Q3 2013 | $101,000 | -19.2% | 25,000 | -16.7% | 0.05% | -24.6% |
| Q2 2013 | $125,000 | – | 30,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |